You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Editor's Correspondence Associations Between Body Mass Index and Risks in Elderly Patients With a First-Ever Acute Ischemic Stroke
Haralampos J. Milionis; John Goudevenos; Konstantine Seferiadis; Moses S. Elisaf
Arch Intern Med 2003; 163: 980.
[Extract][Full text][PDF]
Review Articles Differential Effects of Lipid-Lowering Therapies on Stroke Prevention: A Meta-analysis of Randomized Trials
Jean-Christophe Corvol; Anissa Bouzamondo; Marc Sirol; Jean-Sébastien Hulot; Paola Sanchez; Philippe Lechat
Arch Intern Med 2003; 163: 669-676.
[Abstract][Full text][PDF]
Original Investigations Effect of 1-Year Oral Administration of Dehydroepiandrosterone to 60- to 80-Year-Old Individuals on Muscle Function and Cross-sectional Area: A Double-blind Placebo-Controlled Trial
Original Investigations Hypertension in Acute Ischemic Stroke: A Compensatory Mechanism or an Additional Damaging Factor?
Andrea Semplicini; Andrea Maresca; Gabriele Boscolo; Michelangelo Sartori; Roberta Rocchi; Valter Giantin; Pier Luigi Forte; Achille C. Pessina
Arch Intern Med 2003; 163: 211-216.
[Abstract][Full text][PDF]
Original Investigations Body Mass Index and the Risk of Stroke in Men
Tobias Kurth; J. Michael Gaziano; Klaus Berger; Carlos S. Kase; Kathryn M. Rexrode; Nancy R. Cook; Julie E. Buring; JoAnn E. Manson
Arch Intern Med 2002; 162: 2557-2562.
[Abstract][Full text][PDF]
Original Investigations Plasma Measurement of D-Dimer Levels for the Early Diagnosis of Ischemic Stroke Subtypes
Walter Ageno; Sergio Finazzi; Luigi Steidl; Maria Grazia Biotti; Valentina Mera; GianVico Melzi d'Eril; Achille Venco
Arch Intern Med 2002; 162: 2589-2593.
[Abstract][Full text][PDF]
Review Articles Immunomodulatory Agents for the Treatment of Relapsing Multiple Sclerosis: A Systematic Review
Steven L. Galetta; Clyde Markowitz; Andrew G. Lee
Arch Intern Med 2002; 162: 2161-2169.
[Abstract][Full text][PDF]
Original Investigations Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events